JOIN OUR USA EAST COAST 2018 STRATEGY MEETING
6th November 2018 | The Westin Boston Waterfront
OUR UNIQUE FORMAT
The Clinical Operations Roundtable Discussions Strategy Meeting is free to attend for qualified end-users. These include Senior Executives of Clinical Operations (from medium to large Pharma, Biopharma and Biotech players) as well as thought leaders from Academia and regulatory authorities.
Thought leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
– Clinical Operations, Data Sciences, Clinical Outsourcing, Patient Recruitment, eTMF, Safety Data Management, Clinical Trial Management, Data Acquisition Technology and Integrations, Clinical, Pharmacology Scientific Operations, Clinical Informatics and Innovation.
KEY OPINION LEADERS
Ran FrenkelChief Development and Operations Officer
Karyopharm Therapeutics Inc.
Michael MeyersChief Medical Officer
Eyal RonChief Technology Officer
Ana SharmaGlobal Head, Strategy and Operations, Clinical Development Quality
Heather DibenedettoVice President, Therapeutics Operations
Murray AbramsonVice President, Global Clinical Operations
Charlotte FrenchExecutive Director Outsourcing & Contracts, Medical and Development
Marie-Christine Poisson-CarvajalDirector Head of TMF Operations
WHAT TO EXPECT
Interactive Roundtable Discussions
Attendees can proactively share and ask questions to their peers about the success of their work in an informal setting.
Director level one-to-one meetings
We provide opportunities to engage with one another in our strategy meeting in a series of pre-arranged business meetings by interacting face to face.
Tailor-fit and Personalized Agenda
Being able to experience different sessions is what makes our event unique that’s why our attendees can personalize and select sessions they want to participate in.
Several networking opportunities are in store for attendees to connect and build new relationships with their peers through luncheons, cocktails and informal introductions.
Thank you for reaching Proventa International
***The information you provided in this website is confidential and the company will strictly forbidden to share any part of these information with any third party without a written consent of the sender.
Our unique strategy meeting platform ensures that delegates can network with peers and benchmark their challenges whilst meeting a select number of supplier organizations that are currently at the forefront of innovation. This in turns helps them to save time and money associated in sourcing the best suppliers to procure solutions in an environment, which is 100% conducive to doing business.
If you are an exciting start-up trying to get your innovation in front global heads from the leading Pharmaceutical companies, or a mature market-leading conglomerate with legacy solutions trying to stay one step ahead of the competition – we are here to help!
WHAT PEOPLE SAY
Clinical Operations Strategy Meeting US 2017,
Chief Executive Officer
Its very constructive, my experience is a variety of events that I'll always got the most views out of interactions and being able to challenge each one another.
Director MRL Logistics
You really getting to know each other. Very nice mixed in gaining different perspective into it. I want to participate in meeting again because you can have open and share discussions, you were working with others and dealing with the same challenges.
President, Global Biopherm Solutions
It is a really good one, it gives an opportunity to leads and share what they know, asked questions before they can walk away in that meeting.
Executive Director, Global Clinical Supply Chain
The rountable discussions format helps me learn, getting to know them and learn challenges that they'll have. It keeps me awake and energized, So I like it! and its works for me.
Images coming soon
425 Summer St, Boston, MA 02210, USA
OUR MEDIA PARTNERS
Chief Medical Officer, Versartis
Senior Vice President Clinical Research, Northwest Biotherapeutics
Vice President Clinical and Regulatory Affairs, OncoCyte Corporation
Mary Rose Keller
Vice President Clinical Operations, Heron Therapeutics
Vice President Clinical Operations,
Vice President Clinical Operations, Blaze BioScience
Global Head, Clinical Operations Systems and
Process Excellence, Genentech
Michael is the Global Head of Systems and Process Excellence for late stage Clinical Operations (PDG) at Roche and a member of the Clinical Operations leadership team. He is accountable for supporting infrastructure, tools, processes, and systems enabling the operation of Roche’s clinical trials globally, across multiple study phases. He sits on several committees overseeing, systems, data, and infrastructure projects across Roche’s late stage portfolio operations. Previous to his role in Clinical Operations, Mr. Rosenblatt was the Global Head of Regulatory Technology for late stage . Prior to joining Roche, Mr. Rosenblatt was a life sciences consultant for IBM. He has also held numerous consulting, sales, marketing, and operational roles for several other US-based enterprises.